Democratic Republic of Congo vs Djibouti: Antiretroviral therapy coverage for PMTCT
Democratic Republic of Congo
32.0%
in 2024
Djibouti
38.0%
in 2024
Democratic Republic of Congo rank
75th
Djibouti rank
74th
Antiretroviral therapy coverage for PMTCT over time
- Democratic Republic of Congo
- Djibouti
How they compare
Djibouti currently reports 38.0% against 32.0% in Democratic Republic of Congo, a difference of 6.0%.
That makes Djibouti's figure about 1.2 times Democratic Republic of Congo's.
The two have swapped places 8 times across 25 shared years of data; in 2000 it was Djibouti ahead.
Democratic Republic of Congo ranks 75th and Djibouti ranks 74th of 84 countries.
Across the 3 decades both report, Democratic Republic of Congo averaged higher in 2 and Djibouti in 1.
Head to head by decade
| Decade | Democratic Republic of Congo | Djibouti | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.8% | 6.4% | 1.6% | Djibouti |
| 2010s | 34.5% | 28.2% | 6.3% | Democratic Republic of Congo |
| 2020s | 37.2% | 34.0% | 3.2% | Democratic Republic of Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Democratic Republic of Congo or Djibouti?
- Djibouti, at 38.0% against 32.0% in Democratic Republic of Congo as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Democratic Republic of Congo and Djibouti?
- 6.0%, with Djibouti ahead.
- How many years of comparable data are there for Democratic Republic of Congo and Djibouti?
- 25 years are reported by both, from 2000 to 2024.
- How do Democratic Republic of Congo and Djibouti rank globally for antiretroviral therapy coverage for pmtct?
- Democratic Republic of Congo ranks 75th and Djibouti ranks 74th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).